Polycystic kidney disease: Identifying a pathogenic pathway

Dr Giovanna Musco - San Raffaele Scientific Institute, Milan, Italy
Polycystic kidney disease: Identifying a pathogenic pathway ( Dr Giovanna Musco - San Raffaele Scientific Institute, Milan, Italy )
11 Feb 2016

What does the iManageCancer project hope to achieve?

Prof Gordon McVie - ecancer Managing Editor
What does the iManageCancer project hope to achieve? ( Prof Gordon McVie - ecancer Managing Editor )
23 Dec 2015

Cancer-associated thrombosis: Switching patients to warfarin after 6-month completion of anticoagulant treatment

Dr Chatree Chai-Adisaksopha - McMaster University, Hamilton, Canada
Cancer-associated thrombosis: Switching patients to warfarin after 6-month completion of anticoagulant treatment ( Dr Chatree Chai-Adisaksopha - McMaster University, Hamilton, Canada )
5 Dec 2015

Study suggests warfarin is acceptable for long-term treatment of cancer-associated thrombosis

Dr Chatree Chai-Adisaksopha - McMaster University, Hamilton, Canada
Study suggests warfarin is acceptable for long-term treatment of cancer-associated thrombosis ( Dr Chatree Chai-Adisaksopha - McMaster University, Hamilton, Canada )
5 Dec 2015

Cancer Core Europe: where did it come from and what is its future?

Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark
Cancer Core Europe: where did it come from and what is its future? ( Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark )
4 Dec 2015

Mouse tumour models in the EurocanPlatform project

Prof Anton Berns - Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
Mouse tumour models in the EurocanPlatform project ( Prof Anton Berns - Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands )
4 Dec 2015

Clinical epidemiology in the EurocanPlatform project

Prof Hermann Bremmer - German Cancer Research Center (DKFZ), Heidelberg, Germany
Clinical epidemiology in the EurocanPlatform project ( Prof Hermann Bremmer - German Cancer Research Center (DKFZ), Heidelberg, Germany )
4 Dec 2015

Therapeutic strategies in the EurocanPlatform project

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Therapeutic strategies in the EurocanPlatform project ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
4 Dec 2015

Quality assessment, accreditation and metrics in the EurocanPlatform project

Dr Wim van Harten - Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
Quality assessment, accreditation and metrics in the EurocanPlatform project ( Dr Wim van Harten - Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands )
4 Dec 2015

Biobanking in the EurocanPlatform project

Dr Peter Riegman - Erasmus University Medical Centre, Rotterdam, The Netherlands
Biobanking in the EurocanPlatform project ( Dr Peter Riegman - Erasmus University Medical Centre, Rotterdam, The Netherlands )
4 Dec 2015

Education and training in the EurocanPlatform project

Dr Angelo Paradiso - National Cancer Research Institute, Bari, Italy
Education and training in the EurocanPlatform project ( Dr Angelo Paradiso - National Cancer Research Institute, Bari, Italy )
4 Dec 2015

Highlights of the EurocanPlatform Project

Highlights of the EurocanPlatform Project (  )
2 Dec 2015